R&P- Well, that's a decent valuation. Ever consider how much it would be worth to a company to skip 6 months of the approval process and be the first with an an FDA-approved Covid-19 vaccine?
Maybe not. Definitely blurry in the vision of investors and traders are basically blind.
The value of anything is what someone is willing to pay for it.